Evidence map›Paper›PMID 20160274›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2010

Accuracy of perceived risk of recurrence among patients with early-stage breast cancer.

Ying Liu, Maria Pérez, Rebecca L Aft, Kerry Massman, Erica Robinson, Stephanie Myles, Mario Schootman, William E Gillanders, Donna B Jeffe

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 53 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Fear of cancer recurrence in long-term post-menopausal breast cancer women: evidence from the French national VICAN survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Attitudes and Perceptions Towards Radiation Therapy in Breast Cancer Patients: The Role of a Multidisciplinary Care Team.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021
    Article
  10. Review
  11. Observational
  12. Observational
  13. What does risk of future cancer mean to breast cancer patients?Breast cancer research and treatment · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. What Factors Influence Women's Perceptions of their Systemic Recurrence Risk after Breast Cancer Treatment?Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ying LiuDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63108, USA.
Maria Pérez
Rebecca L Aft
Kerry Massman
Erica Robinson
Stephanie Myles
Mario Schootman
William E Gillanders
Donna B Jeffe
Rush University · USRush University Medical Center · USBarnes-Jewish Hospital · USJohn Cochran VA Medical Center · USMassachusetts General Hospital · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Quality of Life Over Time: DCIS vs Early Breast CancerR01CA102777 · NCI · WASHINGTON UNIVERSITY · PI JEFFE, DONNA B · 2003 to 2007
$1.5M
NCI NIH HHS P30 CA091842NCI NIH HHS P30 CA91842NCI NIH HHS R01 CA102777NCI NIH HHS R01CA102777
6 · The paper itself

Abstract

backgroundAccurate breast cancer recurrence risk perceptions might motivate health-promoting behaviors and alleviate undue anxiety. Although a few studies have examined early-stage breast cancer survivors' perceived risk of recurrence, none have assessed the accuracy of survivors' perceived risk of recurrence.

methodsFirst primary ductal carcinoma in situ and early-invasive breast cancer survivors reported their perceived risk of recurrence during 6- and 12-month postsurgery interviews. We estimated the patients' 10-year risk of recurrence from published clinical trials, and for early-invasive breast cancer patients, risk of distant recurrence was based on their breast cancer-specific mortality calculated using Adjuvant! Online. Patients' perceived risk was compared with their calculated risk and categorized as "Accurate," "Underestimated," "Overestimated," and "Uncertain." Multinomial logit marginal effect models were fitted using Accurate as the reference.

resultsOnly 17% of 531 patients accurately perceived their risk at 6 months, most of whom inaccurately perceived their risk at 12 months (P = 0.0143). Patients who were nonwhite [odds ratio (OR), 1.70; 95% confidence interval (95% CI), 1.12-2.56] and received radiation therapy (OR, 2.01; 95% CI, 1.07-3.77) were more likely to underestimate their risk. Patients with ductal carcinoma in situ (OR, 1.76; 95% CI, 1.11-2.79), [corrected] lower social support (OR, 0.71; 95% CI, 0.53-0.95), and anxiety (OR, 1.58; 95% CI, 1.01-2.47) were more likely to overestimate their risk.

conclusionFew breast cancer survivors accurately perceived their risk of recurrence. IMPACT: The accuracy of perceived risk may be increased by better physician-patient communications about their prognosis, provision of social support, and treatment for coexisting anxiety.

Indexed as

Health Knowledge, Attitudes, PracticeBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma in SituFemaleHumansNeoplasm Recurrence, LocalPerceptionRisk Assessment

Identifiers

PMID20160274
PMCPMC2836416
OpenAlexW2129096256

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.